205 related articles for article (PubMed ID: 34197599)
1. Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.
Bader SB; Ma TS; Simpson CJ; Liang J; Maezono SEB; Olcina MM; Buffa FM; Hammond EM
Nucleic Acids Res; 2021 Jul; 49(13):7492-7506. PubMed ID: 34197599
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
3. DNA replication stress: a source of APOBEC3B expression in breast cancer.
Cescon DW; Haibe-Kains B
Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
[TBL] [Abstract][Full Text] [Related]
4. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
Lindley RA; Hall NE
Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
7. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
Wang S; Jia M; He Z; Liu XS
Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
[TBL] [Abstract][Full Text] [Related]
10. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
11. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
12. Genetic inhibitors of APOBEC3B-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
[TBL] [Abstract][Full Text] [Related]
13. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
[TBL] [Abstract][Full Text] [Related]
14. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
[TBL] [Abstract][Full Text] [Related]
15. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
[TBL] [Abstract][Full Text] [Related]
16. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
17. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Henderson S; Chakravarthy A; Su X; Boshoff C; Fenton TR
Cell Rep; 2014 Jun; 7(6):1833-41. PubMed ID: 24910434
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
19. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines.
Onguru O; Yalcin S; Rosemblit C; Zhang PJ; Kilic S; Gunduz U
Biomed Pharmacother; 2016 Apr; 79():87-92. PubMed ID: 27044816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]